流通市值:407.01亿 | 总市值:470.67亿 | ||
流通股本:14.06亿 | 总股本:16.26亿 |
报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 17,187,621,128.03 | 16,225,312,104.65 | 19,754,460,865.1 | 21,308,844,204.44 |
应收票据及应收账款 | 17,344,100,562.46 | 17,409,355,399.91 | 17,493,056,241.77 | 15,983,379,076.61 |
其中:应收票据 | 661,646,959.52 | 689,744,996.56 | 777,483,311.87 | 870,884,277.92 |
应收账款 | 16,682,453,602.94 | 16,719,610,403.35 | 16,715,572,929.9 | 15,112,494,798.69 |
应收款项融资 | 3,691,555,356.71 | 3,929,323,925.32 | 5,077,739,748.73 | 3,614,318,262.22 |
预付款项 | 648,228,211.86 | 708,489,026.15 | 982,772,001.46 | 818,359,584.97 |
其他应收款合计 | 971,409,619.58 | 1,059,017,904.96 | 1,116,343,169.44 | 878,488,529.23 |
应收股利 | 1,500,000 | 1,500,000 | 61,263,627.92 | 61,263,627.92 |
存货 | 11,343,343,001.98 | 10,751,102,676.63 | 9,848,755,918.4 | 11,507,099,742.41 |
一年内到期的非流动资产 | 272,583,087.55 | 254,950,003.63 | 283,956,458.97 | 159,360,467.41 |
其他流动资产 | 1,577,431,199.5 | 1,598,522,880.96 | 1,398,730,332.1 | 1,709,863,857.8 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 53,050,272,167.67 | 51,940,073,922.21 | 55,959,814,735.97 | 55,983,713,725.09 |
非流动资产: | ||||
债权投资 | 9,572,870,216.64 | 9,525,159,269.21 | 6,454,044,398.27 | 6,536,371,536.43 |
长期股权投资 | 1,925,933,854.41 | 1,801,208,706.7 | 1,826,105,259.49 | 1,805,641,584.3 |
其他权益工具投资 | 104,395,893.53 | 104,194,132.46 | 104,478,175.4 | 103,811,737.94 |
其他非流动金融资产 | 1,023,354,983.18 | 1,006,381,920.06 | 1,014,177,198.31 | 1,005,936,165.09 |
投资性房地产 | 147,660,991.48 | 146,782,364.46 | 150,057,281.64 | 169,774,679.12 |
固定资产 | 4,356,950,543.78 | 4,424,550,998.08 | 4,348,460,620.37 | 4,379,797,422.14 |
在建工程 | 2,831,054,407.86 | 2,690,364,076.29 | 2,517,407,139.96 | 2,405,171,721.7 |
生产性生物资产 | 1,843,597.5 | 1,930,950 | 2,018,302.5 | 2,105,655 |
使用权资产 | 637,560,926.04 | 676,541,564.55 | 706,324,208.47 | 728,902,362.98 |
无形资产 | 2,841,925,329.68 | 2,856,101,215.34 | 2,868,175,243.95 | 2,886,413,941.35 |
开发支出 | 366,380,763.41 | 351,784,901.77 | 333,017,871.02 | 309,893,312.45 |
商誉 | 830,854,604.98 | 830,854,604.98 | 829,473,066.9 | 829,473,066.9 |
长期待摊费用 | 188,722,297.55 | 184,892,068.16 | 185,740,557.77 | 189,876,764.45 |
递延所得税资产 | 1,169,585,791.71 | 1,219,385,254.12 | 1,191,522,687.25 | 1,163,548,295.53 |
其他非流动资产 | 206,174,130.28 | 210,454,868.36 | 212,673,521.23 | 86,445,793.62 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 26,205,268,332.03 | 26,030,586,894.54 | 22,743,675,532.53 | 22,603,164,039 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 79,255,540,499.7 | 77,970,660,816.75 | 78,703,490,268.5 | 78,586,877,764.09 |
流动负债: | ||||
短期借款 | 9,414,703,611.84 | 9,242,343,632.6 | 9,481,235,121.45 | 7,799,035,643.76 |
应付票据及应付账款 | 16,347,213,040.14 | 15,288,619,130.21 | 15,142,204,416.88 | 15,685,867,827.7 |
其中:应付票据 | 3,653,081,930.96 | 3,336,181,202.96 | 3,854,324,119.88 | 3,844,035,975.33 |
应付账款 | 12,694,131,109.18 | 11,952,437,927.25 | 11,287,880,297 | 11,841,831,852.37 |
预收款项 | 5,254,530.28 | 5,960,836.72 | - | - |
合同负债 | 1,206,350,238.66 | 1,449,634,327.13 | 1,849,035,201.43 | 5,429,885,396.19 |
应付职工薪酬 | 1,050,458,849.31 | 1,038,995,350.57 | 959,683,199.58 | 1,068,998,831.85 |
应交税费 | 373,520,307.07 | 443,407,282.1 | 713,114,894.01 | 386,552,287 |
其他应付款合计 | 6,280,261,487.59 | 5,779,079,848.44 | 5,493,444,663.47 | 4,919,241,645.67 |
应付股利 | 698,685,214.52 | 213,876,683.31 | 54,764,494.91 | 62,206,330.91 |
一年内到期的非流动负债 | 1,438,609,020.17 | 849,642,196.54 | 253,064,128.27 | 249,828,503.72 |
其他流动负债 | 144,207,807.29 | 153,789,720.49 | 228,235,182.9 | 695,880,365.06 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 36,260,578,892.35 | 34,251,472,324.8 | 34,120,016,807.99 | 36,235,290,500.95 |
非流动负债: | ||||
长期借款 | 2,645,148,946.45 | 3,255,043,414.31 | 3,509,787,841.91 | 3,323,717,917.22 |
租赁负债 | 512,296,295.07 | 538,161,660.25 | 559,510,674.77 | 578,192,461.09 |
长期应付款 | 19,666,964.6 | 19,666,964.6 | 19,666,964.6 | 19,971,964.6 |
长期应付职工薪酬 | 291,830.61 | 295,354.75 | 293,371 | 293,264.21 |
预计负债 | 59,353,081.64 | 59,394,015.87 | 55,699,823.85 | 55,930,935.37 |
递延收益 | 1,003,620,506.46 | 1,020,651,106.12 | 1,025,084,163.31 | 1,001,429,861 |
递延所得税负债 | 647,360,599.44 | 655,992,715.75 | 645,872,993.81 | 639,528,919.04 |
其他非流动负债 | 54,136,118.41 | 54,176,704.96 | 54,303,554.22 | 54,698,033.81 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 4,941,874,342.68 | 5,603,381,936.61 | 5,870,219,387.47 | 5,673,763,356.34 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 41,202,453,235.03 | 39,854,854,261.41 | 39,990,236,195.46 | 41,909,053,857.29 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 1,625,790,949 | 1,625,790,949 | 1,625,790,949 | 1,625,790,949 |
资本公积 | 10,113,721,706.21 | 10,113,721,706.21 | 10,105,714,430.9 | 10,105,714,430.9 |
其他综合收益 | -19,403,321.78 | -19,365,524.34 | -22,907,870.47 | -24,344,469.59 |
盈余公积 | 2,252,061,705.12 | 2,252,061,704.14 | 2,252,061,704.15 | 2,252,789,227.3 |
未分配利润 | 22,250,274,007.61 | 22,291,178,690.38 | 22,917,448,933.01 | 20,959,330,809.1 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 36,222,445,046.16 | 36,263,387,525.39 | 36,878,108,146.59 | 34,919,280,946.71 |
少数股东权益 | 1,830,642,218.51 | 1,852,419,029.95 | 1,835,145,926.45 | 1,758,542,960.09 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 38,053,087,264.67 | 38,115,806,555.34 | 38,713,254,073.04 | 36,677,823,906.8 |
负债和股东权益合计 | 79,255,540,499.7 | 77,970,660,816.75 | 78,703,490,268.5 | 78,586,877,764.09 |
公告日期 | 2024-10-26 | 2024-08-31 | 2024-04-27 | 2024-03-16 |
审计意见(境内) | 标准无保留意见 |